 |
|
|
| |
Early On-treatment Responses to Telaprevir Are Lower, but Do Not Differ Significantly between HIV/HCV Co-infected and HCV Mono-infected Patients
|
| |
| |
Reported by Jules Levin
CROI 2012 March 5-8 Seattle, WA
Valerie Martel-Laferriere, Kian Bichoupan, Alexis Pappas, Emily Schonfeld, Alicia Stivala, Marie-Louise Vachon, Michel Ng, Mary Standen, Douglas Dieterich, Andrea Branch
Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA
|
| |
|
|
|
|
|
